Adam J DiPippo

11PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMolecular targetsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Ecosystem services (incl. pollination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 20, 2026
Evaluation of hypomethylating agents with or without venetoclax in patients with accelerated phase and blast phase myeloproliferative neoplasms: a HERO consortium study.

|Oct 05, 2021
Targeting CD123 in BPDCN: an emerging field.

Adam J DiPippo, Nathaniel R Wilson, Naveen Pemmaraju

|Sep 27, 2021
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy.

Adam J DiPippo, Patrick M McDaneld, Frank P Tverdek

|May 28, 2020
Non-Aspergillus invasive mould infections in patients treated with ibrutinib.

Amalia Anastasopoulou, Adam J DiPippo, Dimitrios P Kontoyiannis

|Sep 20, 2018
Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.

Adam J DiPippo, Caitlin R Rausch, Dimitrios P Kontoyiannis

Pageof 2

Frequent Collaborators

3 joint publications

Dimitrios P Kontoyiannis

2 joint publications

Koji Sasaki

2 joint publications

Guillermo Garcia-Manero

2 joint publications

Elias Jabbour